VIDA Diagnostics, Inc.
PrivateLast Round
Debt
Jul 24, 2023
Total Funding Raised
$26.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
VIDA Diagnostics, Inc. operates in Healthcare & Life Sciences and is based in Coralville, Iowa. Its latest recorded funding round was a Debt round in July 2023.
VIDA Diagnostics, Inc. is a healthtech company that provides an AI-powered clinical imaging intelligence platform and services to accelerate the development of therapies for lung, cardiac, and oncology indications.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials, Computer Vision
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VIDA Diagnostics, Inc. Comparables
Compare VIDA Diagnostics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thirona | 90% | |
| Optellum | 85% | |
| Riverain Technologies | 85% |
For institutional investors. Book with your work email.
VIDA Diagnostics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 24, 2023 | ||||
| VC Round | May 4, 2022 | ||||
| Series C Extension | Apr 15, 2020 | ||||
| Series C | Mar 12, 2020 | ||||
| Strategic | Jul 25, 2019 | ||||
Series B | Dec 21, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VIDA Diagnostics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Listwin Ventures | VC Round |
| National Cancer Institute | Grant |
| First Analysis | Series C |
| NIH RADx | Grant |
| UnityPoint Health Ventures | Series C, Strategic |
| OSF Ventures | Series C, Series C Extension |
| Iowa Farm Bureau Federation | Series C, Series A, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 92, 7% of headcount.
- Jan 20, 2026
Monthly visitors increased 39% MoM.
For institutional investors. Book with your work email.
VIDA Diagnostics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VIDA Diagnostics, Inc.'s valuation, stock price, and market status.
Is VIDA Diagnostics, Inc. a public or private company?
VIDA Diagnostics, Inc. is a private company.
What is the current stock price of VIDA Diagnostics, Inc.?
VIDA Diagnostics, Inc. is a private company, so its shares have no public market price. Caplight tracks VIDA Diagnostics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VIDA Diagnostics, Inc. worth (valuation)?
Valuation information for VIDA Diagnostics, Inc. is not publicly available.
Can I buy VIDA Diagnostics, Inc. stock?
VIDA Diagnostics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VIDA Diagnostics, Inc.'s last funding round?
VIDA Diagnostics, Inc.'s most recent funding round was Debt on July 24, 2023.
Who are the main investors in VIDA Diagnostics, Inc.?
Key investors in VIDA Diagnostics, Inc. include National Cancer Institute, First Analysis, NIH RADx, UnityPoint Health Ventures, OSF Ventures.
Will VIDA Diagnostics, Inc. IPO soon?
No public IPO plans have been announced for VIDA Diagnostics, Inc..
How can I track VIDA Diagnostics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in VIDA Diagnostics, Inc.'s shares on secondary markets.